Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.

Leeman-Neill, Rebecca J

Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma. [electronic resource] - Cancer prevention research (Philadelphia, Pa.) Feb 2011 - 230-7 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1940-6215

10.1158/1940-6207.CAPR-10-0249 doi


4-Nitroquinoline-1-oxide--toxicity
Animal Feed
Animals
Carcinogens--toxicity
Carcinoma, Squamous Cell--chemically induced
Commiphora
Disease Models, Animal
ErbB Receptors--antagonists & inhibitors
Erlotinib Hydrochloride
Female
Immunoenzyme Techniques
Mice
Mice, Inbred CBA
Mouth Neoplasms--chemically induced
Plant Extracts--administration & dosage
Plant Gums--administration & dosage
Protein Kinase Inhibitors--therapeutic use
Quinazolines--therapeutic use
STAT3 Transcription Factor--antagonists & inhibitors
Signal Transduction